DexCom Inc

DXCM: XNAS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
VY%LOCK|$r$XXLOCK|<#R<<qd

Dexcom Earnings: Fourth Quarter Held Few Surprises, but Improved Operations Bode Well for 2025

Dexcom delivered 8% quarterly revenue growth, but several one-time expenses, including tax adjustments and intellectual property litigation, drove earnings down 40%.

Sponsor Center